Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation

Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation - Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034818

Enrollment

Registered

2018-11-08

Start date

2018-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Interventions

Patient ingests brown rice-specific gamma-oryzanol for 1 month Patient does not ingest brown rice-specific gamma-oryzanol for 1 month

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet the criteria for chronic functional constipation disease

Exclusion criteria

Exclusion criteria: Decision of ineligibility by a physician

Design outcomes

Primary

Measure	Time frame
Intestinal microbiota at 1 month from randomization (gamma-oryzanol group or control group)	—

Secondary

Measure	Time frame
Short chain fatty acids (Acetic acid, butyric acid, propionic acid, valeric acid) in serum Symptoms of constipation	—

Countries

Japan

Contacts

Public ContactKen-ichi Nagakura

National Hospital Organization Sagamihara National Hospital Department of pediatrics

k.nagakura@foodallergy.jp042-742-8311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026